By: Grace Filby
Posted 12 December 2010
(Introduction: Grace Filby has been following the HPV vaccination program in the United Kingdom since its inception in 2008. What she has documented is a history of deception, missing information and falsehoods put forth as facts by pharmaceutical companies, government health officials, medical professionals and the press. The information she presents is not opinion. She has documented each and every allegation with factual documentation. If you live in the United Kingdom, or anywhere else for that matter, you owe it to yourself and your children to take the time to read her chronicle.)
2008
The British government decided to introduce a new national vaccination programme. The purpose was to prevent deaths from cervical cancer in the future, of which, we were informed, the cause is mostly HPV virus infections. It was to be given in schools to 12 year old girls – also doctors’ surgeries for a catch-up programme to teenage girls.
The government had a choice of 2 brand names from 2 manufacturers.
May 2008
The Department of Health, with newly printed publicity material entitled “Beating Cervical Cancer – the Facts”, circulated 50,000 copies via GPs and Primary Care Trusts and posted it online. Note: the facts and figures about side effects were false. It was soon posted online by numerous NHS Trusts nationwide! Other leaflets gave even less information about known side effects and described them as “quite mild.”
Meanwhile, local authority education chiefs and PCT chiefs sent out letters to parents at the end of the summer term 2008, requesting parental consent. Note: under Gillick law, parental consent would not be required, even for 12 year olds.
The government chose Cervarix manufactured by UK company, Glaxo Smith Kline.
September 2008
The new school term began and immediately the vaccination programme began.
13 September 2008
A Surrey Primary Care Trust press release appeared in our local newspaper:
“The vaccine itself is safe, with no serious side effects reported either in clinical trials or among the hundreds of thousands of women who have received it worldwide.”
18 September 2008
I wrote to the Medicines and Healthcare Products Regulatory Agency alerting them of conflicting reports about safety and side effects.
24 September 2008
National news: a school in Manchester refused the vaccinations on their premises. The letter sent out by the governing body (syndicated by local newspapers) pointed out that staff had noticed pupil absences immediately after the jabs were given in the pilot study there. It also cited its opinion that school was not an appropriate environment in which to vaccinate children.
The press changed the story to make it sound as if the decision was for religious or moral reasons.
30 September 2008
Dr. Philip Bryan (Vigilance and Risk Management of Medicines (VRMM), MHRA) replied to my email, with this bald statement:
“Cervarix is not known to be associated with any serious risks.”
Yet he contradicted that immediately by admitting that ‘Cervarix may very rarely cause anaphylaxis’ – which of course is serious. He did not mention any of the other serious or long-term risks associated with vaccines. He did not mention the European Medicines Agency’s Scientific Discussion document which points out that
55 subjects were withdrawn from the study due to serious or non-serious adverse events including 33 subjects in the HPV vaccine group. (Cervarix)
and nor did he disclose that:
13 foetal deaths were also reported to the Company as pregnancy outcomes.
I will add here that the definition of foetal death is:
death of a foetus weighing at least 500 g or after 20 or more weeks of gestation.
Leave a Reply